GRAIL首席执行官Hans Bishop表示:“癌症是社会面临的重大挑战之一,大多数癌症被发现时为时已晚。我们相信多癌症早期检测技术可以满足巨大的未满足需求,并减轻全世界的癌症负担。通过与Illumina结合,可以更广泛、更快地采用GRAIL创新的多癌症早期血液检测,增加患者的可及性并扩大全球覆盖范围。”参考资料:1.Illumina to Acquire GRAIL to Launch New Era of CancerDetectionhttps://transformingcancerdetection.com/2.Illumina to Acquire Grail for $8B in Cash and Stockhttps://www.genomeweb.com/business-news/illumina-acquire-grail-8b-cash-and-stock#.X2mfoON2ttg